E
Epizyme
Biotech & Life Sciences · Cambridge, United States · Founded 2007 · IPO 2013
Valuation
$249M
Revenue
$74M
Power Law
Colt$25–100M revenue
Talent graph
Epizyme's talent
Founders
Hidden — book a demo/100
quality score
Key operators
Hidden — book a demo
quality score
Potential founders
Hidden — book a demo
likely future founders
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Epizyme mafia
Startups founded by Epizyme alumni
Former Epizyme employees who went on to start their own companies. Sorted by Dealroom signal score.
Vesigen TherapeuticsEst. 2019
Robert MillmanUnited StatesSignal score69
RulaiEst. 2016
YZYi ZhangUnited States
Signal score69
Accent TherapeuticsEst. 2017
Robert A. CopelandUnited StatesSignal score68
Menlo MicroEst. 2016
RSRisa StackUnited States
Signal score65
Gritstone OncologyEst. 2015
Andrew AllenUnited StatesSignal score65
Verseau TherapeuticsEst. 2017
Igor FeldmanUnited StatesSignal score59
Disarm TherapeuticsEst. 2016
JRJason RhodesUnited States
Signal score53
Global footprint
Where Epizyme has talent and traffic
Market sentiment
What the market is saying about Epizyme
An AI-synthesized read of the highest-engagement posts about Epizyme on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Epizyme on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.